Prevalence of symptoms of COVID-19 in the state of Rio Grande do Sul: results of a population-based study with 18,000 participants

Authors

DOI:

https://doi.org/10.11606/s1518-8787.2021055004030

Keywords:

COVID-19, Signs and Symptoms, Symptoms Hierarchy, COVID-19 Serological Testing, Predictive Value of Tests, Seroepidemiologic Studies

Abstract

OBJECTIVE: To evaluate the prevalence of reports of symptoms of COVID-19 among individuals with and without antibodies and identify those with greater capability to predict the presence of antibodies against Sars-CoV-2.

METHODS: The study uses data collected in phases 5 to 8 of Epicovid-19-RS. The presence of antibodies against Sars-CoV-2 was evaluated by a rapid test. The occurrence of cough, fever, palpitations, sore throat, difficulty breathing, changes in taste and smell, vomiting, diarrhea, body pain, shaking, and headache since March 2020 was also evaluated. Then, the capability to predict the evaluated symptoms concerning the presence of antibodies was calculated.

RESULTS: A total of 18,000 individuals were interviewed and 181 had antibodies against COVID-19 in phases 5 to 8. The proportion of asymptomatic individuals was 19.9% among participants with antibodies and 49.7% among those without antibodies. All symptoms were reported more frequently by individuals with antibodies. The division of the prevalence of symptoms among individuals with antibodies by the prevalence among individuals without antibodies showed the following prevalence ratios: for changes in smell or taste (9.1), fever (4.2), tremors (3.9), breathing difficulty (3.2) and cough (2.8 times). Anosmia and fever were the symptoms with a greater capability to predict the presence of antibodies.

CONCLUSION: The prevalence of symptoms was higher among individuals with antibodies against Sars-CoV-2. The proportion of asymptomatic individuals was low. Altered smell or taste and fever were the symptoms that most predict the presence of antibodies. These results can help to identify probable cases, contributing to the clinical diagnosis and screening of patients for testing and isolation guidance in positive cases, especially in scenarios of the scarcity of diagnostic COVID-19 tests.

References

World Health Organization. WHO announces COVID-19 outbreak a pandemic. Geneva (CH): WHO; 2020 [citado 15 mai0 2021]. Disponível em: https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/news/news/2020/3/who-announces-covid-19-outbreak-a-pandemic

World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. Geneva (CH): WHO; 2020 [citado 15 mai0 2021]. Disponível em: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes- it

Zhu J, Zhong Z, Ji P, Li H, Li B, Pang J, et al. Clinicopathological characteristics of 8697 patients with COVID-19 in China: a meta-analysis. Fam Med Community Health. 2020;8(2):e000406. https://doi.org/10.1136/fmch-2020-000406

Menezes AMB, Victora CG, Hartwig FP, Silveira MF, Horta BL, Barros AJD, et al. High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2: a nationwide household survey. Sci Rep. 2021;11:13279. https://doi.org/10.1038/s41598-021-92775-y

Li R, Pei S, Chen B, Song Y, Zhang T, Yang W, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science. 2020;368(6490):489-93. https://doi.org/10.1126/science.abb3221

Day M. Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village. BMJ. 2020;368:m1165. https://doi.org/10.1136/bmj.m1165

Siordia JA Jr. Epidemiology and clinical features of COVID-19: a review of current literature. J Clin Virol. 2020;127:104357. https://doi.org/10.1016/j.jcv.2020.104357

Van Elslande J, Oyaert M, Ailliet S, Van Ranst M, Lorent N, Vande Weygaerde Y, et al. Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection. J Clin Virol. 2021;136:104765. https://doi.org/10.1016/j.jcv.2021.104765

Silva AAM, Lima-Neto LG, Azevedo CMPS, Costa LMM, Bragança MLBM, Barros Filho AKD, et al. Population-based seroprevalence of SARS-CoV-2 and the herd immunity threshold in Maranhão. Rev Saude Publica. 2020;54:131. https://doi.org/10.11606/s1518-8787.2020054003278

Pollán M, Pérez-Gómez B, Pastor-Barriuso R, Oteo J, Hernán MA, Pérez-Olmeda M, et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Lancet. 2020;396(10250):535-44. https://doi.org/10.1016/S0140-6736(20)31483-5

Hallal PC, Horta BL, Barros AJD, Dellagostin OA, Hartwig FP, Pellanda LC, et al. Trends in the prevalence of COVID-19 infection in Rio Grande do Sul, Brazil: repeated serological surveys. Cienc Saude Coletiva. 2020;25 Suppl 1:2395-401. https://doi.org/10.1590/1413-81232020256.1.09632020

Pellanda LC, Ros Wendland EM, McBride AJA, Tovo-Rodrigues L, Ferreira MRA, Dellagostin OA, et al. Sensitivity and specificity of a rapid test for assessment of exposure to SARS-CoV-2 in a community-based setting in Brazil. medRxiv [Preprint]. 2020. https://doi.org/10.1101/2020.05.06.20093476

Silveira MF, Mesenburg MA, Dellagostin OA, Oliveira NR, Maia MAC, Santos FDS. Time-dependent decay of detectable antibodies against SARS-CoV-2: a comparison of ELISA with two batches of a lateral-flow test. SSRN Electron J [Preprint]. 2021. https://doi.org/10.2139/ssrn.3757411

Buri M, Tanadini LG, Hothorn T, Curt A. Unbiased recursive partitioning enables robust and reliable outcome prediction in acute spinal cord injury. J Neurotrauma. 2021 Apr 7. https://doi.org/10.1089/neu.2020.7407

Seow J, Graham C, Merrick B, Acors S, Steel KJA, Hemmings O, et al. Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection. medRxiv [Preprint]. 2020. https://doi.org/10.1101/2020.07.09.20148429

Long QX, Tang XJ, Shi QL, Li Q, Deng HJ, Yuan J, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020;26:1200-4. https://doi.org/10.1038/s41591-020-0965-6

Published

2021-11-22

Issue

Section

Original Articles

How to Cite

Mesenburg, M. A. ., Hallal, P. C., Menezes, A. M. B., Barros, A. J. D., Hortah, B. L., Hartwig, F. P., Jacques, N., Pellanda, L. C., Zelmanowicz, A. de M., Vergani, D. O. P., Ries, E. F., Harter, J., Martínez-Mesa, J., Carneiro, M., Estima, S. L. ., Heck, T. G., & Silveira, M. F. da. (2021). Prevalence of symptoms of COVID-19 in the state of Rio Grande do Sul: results of a population-based study with 18,000 participants. Revista De Saúde Pública, 55, 82. https://doi.org/10.11606/s1518-8787.2021055004030